NCT01311661 A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma Status COMPLETED Phase PHASE2
NCT01309139 Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01307189 Effects of Tiotropium on Walking Capacity in Patients With COPD Status COMPLETED Phase PHASE4
NCT01306214 Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01306162 Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01304329 Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin Status COMPLETED Phase PHASE1
NCT01303445 Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers Status COMPLETED Phase PHASE1
NCT01301742 Relative Bioavailability of Single Dose Empagliflozin (BI 10773) When Co-administered With Multiple Doses of 600 mg Gemfibrozil Compared to Single Dose Treatment With Empagliflozin (BI 10773) When Given Alone in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01298063 Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib Status COMPLETED Phase PHASE1
NCT01297270 Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2) Status COMPLETED Phase PHASE3
NCT01296932 BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL) Status COMPLETED Phase PHASE1
NCT01293890 Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective Study Status UNKNOWN Phase N/A
NCT01291732 Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers. Status COMPLETED Phase PHASE1
NCT01290757 Bioequivalence of Two Different Capsule Types of Dabigatran Status COMPLETED Phase PHASE1
NCT01289990 Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01286571 Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food Status COMPLETED Phase PHASE1
NCT01286558 Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg) Status COMPLETED Phase PHASE3
NCT01284621 Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers Status COMPLETED Phase PHASE1